Skyrizi 00074-1065

Generic: Risankizumab-Rzaa

Product NDC

00074-1065

Manufacturer: Abbvie Inc.
Dosage Form: Kit
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: September 23, 2022
Listing Expires: December 31, 2027
Application: BLA761105

Need to source Skyrizi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Drug Class

Interleukin-23 Antagonist [EPC]

Packaging Options(2)

00074-1065-01

1 KIT in 1 CARTON (0074-1065-01) * 1.2 mL in 1 CARTRIDGE (0074-1066-02) * 1.2 mL in 1 CARTRIDGE (0074-1066-01)

View →

00074-1065-02

1 KIT in 1 CARTON (0074-1065-02) * 1.2 mL in 1 CARTRIDGE (0074-1066-02) * 1.2 mL in 1 CARTRIDGE (0074-1066-01)

View →